A Protocol for the Investigation of Malignant Hyperpyrexia (MH) Susceptibility. The European Malignant Hyperpyrexia Group

Overview

Journal Br J Anaesth

Publisher Elsevier

Specialty Anesthesiology

Date 1984 Nov 1

PMID 6487446

Citations 64

Affiliations

Soon will be listed here.

Abstract

A European Malignant Hyperpyrexia Group has been formed to facilitate exchange of information between centres performing in vitro muscle testing for malignant hyperpyrexia susceptibility. Data have been collected according to a protocol agreed by the Group. Based on these results, test criteria have been established to allow the following diagnoses to be made: MH susceptible (MHS); MH normal (MHN) or MH equivocal (MHE). It is accepted that MHE classified patients will be under permanent review, pending the collection of further data.

Citing Articles

Detection of the T1640C mutation indicating malignant hyperthermia in dogs.

Haluskova J, Holeckova B, Kokulova L, Galdikova M, Bucan J, Schwarzbacherova V Vet Med (Praha). 2024; 68(11):428-434.

PMID: 38163044 PMC: 10755811. DOI: 10.17221/46/2023-VETMED.

Exertional heat stroke causes long-term skeletal muscle epigenetic reprogramming, altered gene expression, and impaired satellite cell function in mice.

Murray K, Brant J, Spradlin R, Thome T, Laitano O, Ryan T Am J Physiol Regul Integr Comp Physiol. 2023; 326(2):R160-R175.

PMID: 38047316 PMC: 11283893. DOI: 10.1152/ajpregu.00226.2023.

Muscle Ultrasound Abnormalities in Individuals with RYR1-Related Malignant Hyperthermia Susceptibility.

Bersselaar L, van Alfen N, Kruijt N, Kamsteeg E, Fernandez-Garcia M, Treves S J Neuromuscul Dis. 2023; 10(4):541-554.

PMID: 37154182 PMC: 10357171. DOI: 10.3233/JND-230018.

Neuromuscular symptoms in patients with -related malignant hyperthermia and rhabdomyolysis.

Bersselaar L, Jungbluth H, Kruijt N, Kamsteeg E, Fernandez-Garcia M, Treves S Brain Commun. 2023; 4(6):fcac292.

PMID: 36751502 PMC: 9897183. DOI: 10.1093/braincomms/fcac292.

Malignant Hyperthermia in PICU-From Diagnosis to Treatment in the Light of Up-to-Date Knowledge.

Klincova M, Stepankova D, Schroderova I, Klabusayova E, Stourac P Children (Basel). 2022; 9(11).

PMID: 36360420 PMC: 9717737. DOI: 10.3390/children9111692.